Jens Knobe
Direttore/Membro del Consiglio presso SOLIDX AB
Profilo
Jens Knobe currently works at SARomics Biostructures AB, as Director, SolidX AB, as Independent Director from 2021, Knobe Strat&Med AB, as Director, Fastighets AB Swenson & Co., as Director, and Radiometer A, as Vice President-Marketing from 2005.
Mr. Knobe received his graduate degree in 1987 from the University of Lund and graduate degree from the University of Lund.
Posizioni attive di Jens Knobe
Società | Posizione | Inizio |
---|---|---|
SOLIDX AB | Direttore/Membro del Consiglio | 01/07/2021 |
Radiometer A/S
Radiometer A/S Medical SpecialtiesHealth Technology Radiometer A/S develops as well as manufactures blood gas instruments and support devices. It supplies blood gas analyzers that measure blood gases and other parameters used to diagnose critically ill patients. It also provides accessories, IT systems and support services for blood gas testing, besides producing instruments that measure blood gases transcutaneously. The company consists of three subsidiaries Radiometer Medical ApS (Denmark), SenDx Medical, Inc. (US) and Radiometer Basel AG (Switzerland). Radiometer was founded in 1935 and is headquartered in Br?nsh?j, Denmark. | Vendite & Marketing | 01/01/2005 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Direttore/Membro del Consiglio | - |
Knobe Strat&Med AB | Direttore/Membro del Consiglio | - |
Fastighets AB Swenson & Co. | Direttore/Membro del Consiglio | - |
Formazione di Jens Knobe
University of Lund | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SOLIDX AB | Commercial Services |
Aziende private | 4 |
---|---|
Radiometer A/S
Radiometer A/S Medical SpecialtiesHealth Technology Radiometer A/S develops as well as manufactures blood gas instruments and support devices. It supplies blood gas analyzers that measure blood gases and other parameters used to diagnose critically ill patients. It also provides accessories, IT systems and support services for blood gas testing, besides producing instruments that measure blood gases transcutaneously. The company consists of three subsidiaries Radiometer Medical ApS (Denmark), SenDx Medical, Inc. (US) and Radiometer Basel AG (Switzerland). Radiometer was founded in 1935 and is headquartered in Br?nsh?j, Denmark. | Health Technology |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Health Technology |
Knobe Strat&Med AB | |
Fastighets AB Swenson & Co. |
- Borsa valori
- Insiders
- Jens Knobe